http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110229797-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y202-01006 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P13-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-1022 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P13-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-10 |
filingDate | 2019-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2020-08-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2020-08-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-110229797-B |
titleOfInvention | Acetohydroxy acid synthetase and application thereof |
abstract | The invention relates to an acetohydroxy acid synthetase for relieving feedback inhibition of L-isoleucine and application thereof, belonging to the field of metabolic engineering. Said ilvBN according to the invention M The gene-coded acetohydroxy acid synthetase has the following characteristics: the enzyme has no feedback inhibition effect of L-isoleucine, and under the condition of L-isoleucine concentration of 0-12mmol/L, ILVBN M The enzyme activity has no obvious change, and the activity of the acetohydroxy acid synthetase is not obviously reduced compared with that of wild ilvBN, so that the acetohydroxy acid synthetase can be applied to the production of L-isoleucine. |
priorityDate | 2019-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 471.